Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec;59(6):102904.
doi: 10.1016/j.transci.2020.102904. Epub 2020 Aug 3.

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia

Erhan Tatar  1 , Murat Karatas  2 , Ilter Bozaci  3 , Alpay Ari  4 , Turker Acar  5 , Cenk Simsek  3 , Ali Murat Yildirim  3 , Ozden Yildirim  3 , Adam Uslu  2
Affiliations
Case Reports

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia

Erhan Tatar et al. Transfus Apher Sci. 2020 Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Thorax CT During The Follow-up of The Case
Fig. 2
Fig. 2
Treatment Protocol and Laboratuvar Results During The Follow-up of The Case
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sissoko D., Laouenan C., Folkesson E, JIKI Study Group Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016;13(Mar. (3)) - PMC - PubMed
    1. Du YX, Chen XP. Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection. Clin Pharmacol Ther. 2020;(April):3. doi: 10.1002/cpt.1844. - DOI - PubMed
    1. Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422. - PMC - PubMed
    1. Blasczyk R., Westhoff U., Grossewilde H. Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet. 1993;341:789–790. - PubMed
    1. Jordan SC, Toyoda M, Kahwaji J. Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients. Am J Transplant. 2011;11:196–202. - PubMed